Moderate Aplastic Anemia in Children: Preliminary Outcomes for Treatment Versus Observation from a Single-Institutional Experience.
J. Pediatr. Hematol. Oncol., Nov (2012)
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.
Oncogene., Aug (2012)
Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia.
ACS Med Chem Lett., Feb;3(2):129-134 (2012)
Prolonged exposure to a Mer ligand in leukemia: Gas6 favors expression of a partial Mer glycoform and reveals a novel role for Mer in the nucleus.
PLoS ONE., 7(2):e31635 (2012)
TAM receptors in leukemia: expression, signaling, and therapeutic implications.
Crit Rev Oncog., 16(1-2):47-63 (2011)
Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria.
Mol. Genet. Metab., Aug;103(4):330-7 (2011)
Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development.
Br. J. Haematol., Nov;151(4):295-311 (2010)
Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.
Expert Opin. Ther. Targets., Oct;14(10):1073-90 (2010)
Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.
Mol. Cancer Ther., May;9(5):1298-307 (2010)
Gray zone lymphomas in pediatric patients.
Pediatr. Dev. Pathol., 14(1):57-63 (2011 Jan-Feb)
Thymoma in children: report of 2 cases and review of the literature.
Pediatr. Dev. Pathol., 13(3):202-8 (2010 May-Jun)
Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.
Blood., Sep;114(13):2678-87 (2009)
Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.
J. Leukoc. Biol., Jul;86(1):73-9 (2009)
Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
Pediatr Blood Cancer., May;52(5):626-30 (2009)
Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.
Curr Oncol Rep., Nov;10(6):477-90 (2008)
TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.
Adv. Cancer Res., 100:35-83 (2008)
BAC to the future? comparative genomic hybridization and genotyping pediatric leukemia cytogenetic abnormalities.
Pediatr Blood Cancer., Aug;51(2):153-4 (2008)
Natural killer cell neoplasms.
Cancer., Apr;112(7):1425-36 (2008)
Consensus on a core curriculum in American training programs in pediatric hematology-oncology: a report from the ASPHO Training Committee.
Pediatr Hematol Oncol., 24(7):503-12 (2007 Oct-Nov)
Precursor natural killer cell leukemia.
Pediatr Blood Cancer., Apr;50(4):876-8 (2008)